The University of Kansas Cancer Center

Recent papers from The University of Kansas Cancer Center

1. High Initial Dose and Accelerated vs. Slow Titration Ropeginterferon Alfa-2b for Polycythemia Vera: A Meta-AnalysisBlood Advances · 2026
2. Androgen Synthesis Inhibitors vs Androgen Receptor Inhibitors and Survival in Metastatic Hormone-Sensitive Prostate CancerJAMA Network Open · 2026
3. Long-term efficacy, clinical outcomes, and safety of vimseltinib in patients with tenosynovial giant cell tumor: results from the MOTION phase 3 trialThe Oncologist · 2026
4. Exemplar 1: Clinical Trials Innovations for Rural AreasJNCI Monographs · 2026
5. Survival Outcomes With Lu-177 PSMA by Treatment Line and Taxane Sequencing in Prostate CancerJAMA Network Open · 2026
6. VERIFY: A Phase III Trial of Rusfertide Versus Placebo in Phlebotomy-Dependent Patients With Polycythemia Vera Receiving Standard-of-Care TherapyJournal of Clinical Oncology · 2026
7. NRG-BR002: A Randomized Phase II/III Trial of Metastasis-Directed Ablation With First-Line Systemic Therapy for Oligometastatic Breast CancerJournal of Clinical Oncology · 2026
8. Evaluation of Time to Metastasis After Prostatectomy as a Prognostic Factor in Patients With Metachronous mHSPC: A Secondary Analysis of the SWOG‐1216 Phase 3 TrialThe Prostate · 2026
9. Modeling spatially dependent count time series data using COM-poisson INGARCH ModelsPLoS ONE · 2026
10. Prognostic role of the Child-Turcotte-Pugh classification and ALBI grade in patients without cirrhosis and hepatocellular carcinomaJHEP Reports · 2026
11. Advances in Peptide-Functionalized Polymeric Nanocarriers for Cancer TherapyPharmaceutics · 2026
12. Federated ADMM-IRLS: A privacy-preserving framework for high-dimensional multicenter genomic analysis with binary outcomesBiomedical Signal Processing and Control · 2026
13. Unlocking 30-Year-Old Archival Formalin-Fixed Paraffin-Embedded Breast Cancer Specimens (SWOG S8897): An Analytical Feasibility StudyJCO Precision Oncology · 2026
14. Randomized phase II trial of liposomal cytarabine and daunorubicin with or without pomalidomide in newly diagnosed acute myeloid leukemia myelodysplasia-relatedHaematologica · 2026
15. Embrace Disorder as a Function: Bio-Informed Biomaterials Design Advanced by Intrinsically Disordered ProteinsBiomimetics · 2026
16. TP53 ‐Altered Aggressive Large B‐Cell Lymphoma ( LBCL ) Outcomes by Treatment Modality: A Multicenter Cohort From 14 US CentersEuropean Journal Of Haematology · 2026
17. Carbohydrate‐Directed Labeling Probes for UV‐Independent Chemoproteomic Profiling of Carbohydrate–Protein InteractionsAngewandte Chemie International Edition · 2026
18. Carbohydrate‐Directed Labeling Probes for UV‐Independent Chemoproteomic Profiling of Carbohydrate–Protein InteractionsAngewandte Chemie · 2026
19. Molecular Response, Event-Free Survival, and Treatment-Free Remission in Myeloproliferative Neoplasms: Update and Review with Insights from MPN Asia 2026Current Hematologic Malignancy Reports · 2026
20. Peptide Fingerprinting of Single Protein Molecules Using In‐Plane Nanopore Sensors Integrated to an Extended Immobilized Nanoscale Enzymatic Reactor (eINER)Small Methods · 2026